
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
The Extracellular Matrix in Pancreatic Cancer: Description of a Complex Network and Promising Therapeutic Options
Benedetta Ferrara, Cataldo Pignatelli, Mélissande Cossutta, et al.
Cancers (2021) Vol. 13, Iss. 17, pp. 4442-4442
Open Access | Times Cited: 79
Benedetta Ferrara, Cataldo Pignatelli, Mélissande Cossutta, et al.
Cancers (2021) Vol. 13, Iss. 17, pp. 4442-4442
Open Access | Times Cited: 79
Showing 1-25 of 79 citing articles:
Targeting extracellular matrix stiffness and mechanotransducers to improve cancer therapy
Yangfu Jiang, Hongying Zhang, Jiao Wang, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 262
Yangfu Jiang, Hongying Zhang, Jiao Wang, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 262
Fibroblasts in cancer: Unity in heterogeneity
Yash Chhabra, Ashani T. Weeraratna
Cell (2023) Vol. 186, Iss. 8, pp. 1580-1609
Closed Access | Times Cited: 197
Yash Chhabra, Ashani T. Weeraratna
Cell (2023) Vol. 186, Iss. 8, pp. 1580-1609
Closed Access | Times Cited: 197
Cancer-associated fibroblasts in pancreatic ductal adenocarcinoma
Tianyi Zhang, Yanxian Ren, Pengfei Yang, et al.
Cell Death and Disease (2022) Vol. 13, Iss. 10
Open Access | Times Cited: 96
Tianyi Zhang, Yanxian Ren, Pengfei Yang, et al.
Cell Death and Disease (2022) Vol. 13, Iss. 10
Open Access | Times Cited: 96
Current and future immunotherapeutic approaches in pancreatic cancer treatment
Pooya Farhangnia, Hossein Khorramdelazad, Hamid Nickho, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 36
Pooya Farhangnia, Hossein Khorramdelazad, Hamid Nickho, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 36
The role of laminins in cancer pathobiology: a comprehensive review
Elena Nonnast, E. Mira, Santos Mañes
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access | Times Cited: 2
Elena Nonnast, E. Mira, Santos Mañes
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access | Times Cited: 2
Enhanced Glutaminolysis Drives Hypoxia-Induced Chemoresistance in Pancreatic Cancer
Seung Joon Park, Hee Chan Yoo, Eunyong Ahn, et al.
Cancer Research (2023) Vol. 83, Iss. 5, pp. 735-752
Open Access | Times Cited: 36
Seung Joon Park, Hee Chan Yoo, Eunyong Ahn, et al.
Cancer Research (2023) Vol. 83, Iss. 5, pp. 735-752
Open Access | Times Cited: 36
Anticancer properties of bromelain: State-of-the-art and recent trends
Raffaele Pezzani, Manuel Jiménez-Garcia, Xavier Capó, et al.
Frontiers in Oncology (2023) Vol. 12
Open Access | Times Cited: 35
Raffaele Pezzani, Manuel Jiménez-Garcia, Xavier Capó, et al.
Frontiers in Oncology (2023) Vol. 12
Open Access | Times Cited: 35
Fibroblasts as Turned Agents in Cancer Progression
Robert Wieder
Cancers (2023) Vol. 15, Iss. 7, pp. 2014-2014
Open Access | Times Cited: 27
Robert Wieder
Cancers (2023) Vol. 15, Iss. 7, pp. 2014-2014
Open Access | Times Cited: 27
Tunable hybrid hydrogels with multicellular spheroids for modeling desmoplastic pancreatic cancer
Menekşe Ermis, Natashya Falcone, Natan Roberto de Barros, et al.
Bioactive Materials (2023) Vol. 25, pp. 360-373
Open Access | Times Cited: 24
Menekşe Ermis, Natashya Falcone, Natan Roberto de Barros, et al.
Bioactive Materials (2023) Vol. 25, pp. 360-373
Open Access | Times Cited: 24
Sono-promoted drug penetration and extracellular matrix modulation potentiate sonodynamic therapy of pancreatic ductal adenocarcinoma
Hong Xiao, Xiaoxia Li, Bo Li, et al.
Acta Biomaterialia (2023) Vol. 161, pp. 265-274
Closed Access | Times Cited: 23
Hong Xiao, Xiaoxia Li, Bo Li, et al.
Acta Biomaterialia (2023) Vol. 161, pp. 265-274
Closed Access | Times Cited: 23
Frontiers and future of immunotherapy for pancreatic cancer: from molecular mechanisms to clinical application
Rui Zheng, Xiaobin Liu, Yufu Zhang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 10
Rui Zheng, Xiaobin Liu, Yufu Zhang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 10
New insights into disease dynamics and treatment interventions with PID controller-based therapeutic strategies for pancreatic cancer
David Amilo, Khadijeh Sadri, Muhammad Farman, et al.
Computers & Mathematics with Applications (2025) Vol. 181, pp. 133-162
Closed Access | Times Cited: 1
David Amilo, Khadijeh Sadri, Muhammad Farman, et al.
Computers & Mathematics with Applications (2025) Vol. 181, pp. 133-162
Closed Access | Times Cited: 1
A stumbling block in pancreatic cancer treatment: drug resistance signaling networks
Jinming Liu, Biao Zhang, Bingqian Huang, et al.
Frontiers in Cell and Developmental Biology (2025) Vol. 12
Open Access | Times Cited: 1
Jinming Liu, Biao Zhang, Bingqian Huang, et al.
Frontiers in Cell and Developmental Biology (2025) Vol. 12
Open Access | Times Cited: 1
Pancreatic Cancer and Cellular Senescence: Tumor Microenvironment under the Spotlight
Michela Cortesi, Michele Zanoni, Francesca Pirini, et al.
International Journal of Molecular Sciences (2021) Vol. 23, Iss. 1, pp. 254-254
Open Access | Times Cited: 48
Michela Cortesi, Michele Zanoni, Francesca Pirini, et al.
International Journal of Molecular Sciences (2021) Vol. 23, Iss. 1, pp. 254-254
Open Access | Times Cited: 48
Comprehensive characterization of extracellular matrix-related genes in PAAD identified a novel prognostic panel related to clinical outcomes and immune microenvironment: A silico analysis with in vivo and vitro validation
Xu Chen, Qihang Yuan, Jifeng Liu, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 37
Xu Chen, Qihang Yuan, Jifeng Liu, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 37
The Desmoplastic Stroma of Pancreatic Cancer: Multilayered Levels of Heterogeneity, Clinical Significance, and Therapeutic Opportunities
Yohei Masugi
Cancers (2022) Vol. 14, Iss. 13, pp. 3293-3293
Open Access | Times Cited: 32
Yohei Masugi
Cancers (2022) Vol. 14, Iss. 13, pp. 3293-3293
Open Access | Times Cited: 32
Targeting the Tumor-Tumor Microenvironment Crosstalk
Sunil Badve, Yesim Gökmen–Polar
Expert Opinion on Therapeutic Targets (2023) Vol. 27, Iss. 6, pp. 447-457
Closed Access | Times Cited: 19
Sunil Badve, Yesim Gökmen–Polar
Expert Opinion on Therapeutic Targets (2023) Vol. 27, Iss. 6, pp. 447-457
Closed Access | Times Cited: 19
Nanodrug-bacteria conjugates-mediated oncogenic collagen depletion enhances immune checkpoint blockade therapy against pancreatic cancer
Zhaoting Li, Fanyi Mo, Kai Guo, et al.
Med (2024) Vol. 5, Iss. 4, pp. 348-367.e7
Closed Access | Times Cited: 7
Zhaoting Li, Fanyi Mo, Kai Guo, et al.
Med (2024) Vol. 5, Iss. 4, pp. 348-367.e7
Closed Access | Times Cited: 7
Investigating underlying molecular mechanisms, signaling pathways, emerging therapeutic approaches in pancreatic cancer
Mohd Rais Mustafa, Kashif Abbas, Mudassir Alam, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 6
Mohd Rais Mustafa, Kashif Abbas, Mudassir Alam, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 6
Lysyl hydroxylase LH1 promotes confined migration and metastasis of cancer cells by stabilizing Septin2 to enhance actin network
Zihan Yang, Li Zhou, Tongxu Si, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 16
Zihan Yang, Li Zhou, Tongxu Si, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 16
CAFs Homologous Biomimetic Liposome Bearing BET Inhibitor and Pirfenidone Synergistically Promoting Antitumor Efficacy in Pancreatic Ductal Adenocarcinoma
Zhang Yin, Ranran Yu, Cheng Zhao, et al.
Advanced Science (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 14
Zhang Yin, Ranran Yu, Cheng Zhao, et al.
Advanced Science (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 14
Breaking the stromal barrier in pancreatic cancer: Advances and challenges
Mohana Chakkera, Jeremy B. Foote, Batoul Farran, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2023) Vol. 1879, Iss. 1, pp. 189065-189065
Closed Access | Times Cited: 14
Mohana Chakkera, Jeremy B. Foote, Batoul Farran, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2023) Vol. 1879, Iss. 1, pp. 189065-189065
Closed Access | Times Cited: 14
GATA6 identifies an immune-enriched phenotype linked to favorable outcomes in patients with pancreatic cancer undergoing upfront surgery
Casper W.F. van Eijck, Francisco X. Real, Núria Malats, et al.
Cell Reports Medicine (2024) Vol. 5, Iss. 5, pp. 101557-101557
Open Access | Times Cited: 5
Casper W.F. van Eijck, Francisco X. Real, Núria Malats, et al.
Cell Reports Medicine (2024) Vol. 5, Iss. 5, pp. 101557-101557
Open Access | Times Cited: 5
Crosstalk between tumor acidosis, p53 and extracellular matrix regulates pancreatic cancer aggressiveness
Dominika Czaplińska, Renata Ialchina, Henriette Berg Andersen, et al.
International Journal of Cancer (2022) Vol. 152, Iss. 6, pp. 1210-1225
Open Access | Times Cited: 20
Dominika Czaplińska, Renata Ialchina, Henriette Berg Andersen, et al.
International Journal of Cancer (2022) Vol. 152, Iss. 6, pp. 1210-1225
Open Access | Times Cited: 20
Rethinking the Roles of Cancer-Associated Fibroblasts in Pancreatic Cancer
Ralph Francescone, Howard C. Crawford, Débora B. Vendramini‐Costa
Cellular and Molecular Gastroenterology and Hepatology (2024) Vol. 17, Iss. 5, pp. 737-743
Open Access | Times Cited: 4
Ralph Francescone, Howard C. Crawford, Débora B. Vendramini‐Costa
Cellular and Molecular Gastroenterology and Hepatology (2024) Vol. 17, Iss. 5, pp. 737-743
Open Access | Times Cited: 4